<?xml version="1.0" encoding="UTF-8" ?>








    
    
    
    













        
            
            
        <!-- FT CACHE --> 

<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="http://www.ft.com/FTCOM/XSL/styleRSSFeed.xsl"?><rss xmlns:java="java" xmlns:ft="http://www.ft.com/FTRSSExtensions" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><atom:link type="application/xml" rel="self" href="http://www.ft.com/rss/companies/health"/><title>FT.com - Health</title><link>http://www.ft.com/companies/health</link><ft:rsslink>http://www.ft.com/rss/companies/health</ft:rsslink><description>FT.com - Health</description><language>en</language><copyright>© Copyright The Financial Times Ltd 2012. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.</copyright><webMaster>client.support@ft.com (Client Support)</webMaster><pubDate>Mon, 13 Feb 2012 18:00:06 +0000</pubDate><lastBuildDate>Mon, 13 Feb 2012 19:10:13 +0000</lastBuildDate><category>Newspapers</category><ttl>15</ttl><image><url>http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gif</url><title>FT.com - Health</title><link>http://www.ft.com/companies/health</link></image><rating>(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))</rating><item><title>The coalition is prescribing bad policy and worse politics</title><link>http://www.ft.com/cms/s/0/cd337710-5639-11e1-8dfa-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/cd337710-5639-11e1-8dfa-00144feabdc0.html?ftcamp=rss</guid><description>Whitehall officials fear meltdown. There is still time – just – for the government to change course on NHS reform, writes Philip Stephens
</description><pubDate>Mon, 13 Feb 2012 18:00:06 +0000</pubDate><ft:uid>cd337710-5639-11e1-8dfa-00144feabdc0</ft:uid></item><item><title>Lansley defends role of competition in NHS</title><link>http://www.ft.com/cms/s/0/6699431c-5572-11e1-9d95-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/6699431c-5572-11e1-9d95-00144feabdc0.html?ftcamp=rss</guid><description>Plans to level the playing field between private and NHS providers of healthcare have proved the most contentious aspect of reforms opposed by the medical profession</description><pubDate>Mon, 13 Feb 2012 00:11:26 +0000</pubDate><ft:uid>6699431c-5572-11e1-9d95-00144feabdc0</ft:uid></item><item><title>What voters never hear about the English health service</title><link>http://www.ft.com/cms/s/0/0e542446-540b-11e1-8d12-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/0e542446-540b-11e1-8d12-00144feabdc0.html?ftcamp=rss</guid><description>Many recoil in horror when words such as efficiency and profit are even mentioned in the field of healthcare, writes Iain Martin
</description><pubDate>Sun, 12 Feb 2012 19:33:54 +0000</pubDate><ft:uid>0e542446-540b-11e1-8d12-00144feabdc0</ft:uid></item><item><title>Athens struggles to rein in medical excess</title><link>http://www.ft.com/cms/s/0/5ea22f18-14f2-11e1-a2a6-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/5ea22f18-14f2-11e1-a2a6-00144feabdc0.html?ftcamp=rss</guid><description>High spending on medicines is a striking example of the broader problems facing Greece as it battles under pressure to cut public expenditure </description><pubDate>Sun, 12 Feb 2012 15:00:29 +0000</pubDate><ft:uid>5ea22f18-14f2-11e1-a2a6-00144feabdc0</ft:uid></item><item><title>US mental guidelines attacked</title><link>http://www.ft.com/cms/s/0/2b1cf084-5411-11e1-8d12-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/2b1cf084-5411-11e1-8d12-00144feabdc0.html?ftcamp=rss</guid><description>British health specialists warn that the guidelines could boost inappropriate use of medicines, stigmatise normal behaviours and stretch mental health funding</description><pubDate>Fri, 10 Feb 2012 21:52:58 +0000</pubDate><ft:uid>2b1cf084-5411-11e1-8d12-00144feabdc0</ft:uid></item><item><title>Clegg fury at Tory moves to kill health bill</title><link>http://www.ft.com/cms/s/0/47bcc354-53f8-11e1-bacb-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/47bcc354-53f8-11e1-bacb-00144feabdc0.html?ftcamp=rss</guid><description>Deputy PM furious that three Conservative ministers have been lobbying against the health bill, amid fears the issue could split the Liberal Democrats </description><pubDate>Fri, 10 Feb 2012 21:30:27 +0000</pubDate><ft:uid>47bcc354-53f8-11e1-bacb-00144feabdc0</ft:uid></item><item><title>Vernalis secures backing for US drugs deal</title><link>http://www.ft.com/cms/s/0/eeb4e31a-53eb-11e1-bacb-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/eeb4e31a-53eb-11e1-bacb-00144feabdc0.html?ftcamp=rss</guid><description>UK biotech group nets funding worth £65m, three times its market capitalisation before the announcement of the transaction</description><pubDate>Fri, 10 Feb 2012 16:04:31 +0000</pubDate><ft:uid>eeb4e31a-53eb-11e1-bacb-00144feabdc0</ft:uid></item><item><title>Doughty Hanson buys Spanish hospital chain</title><link>http://www.ft.com/cms/s/0/e1366b70-533f-11e1-aafd-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/e1366b70-533f-11e1-aafd-00144feabdc0.html?ftcamp=rss</guid><description>Private equity group buys USP from RBS for €355m in deal that underlines how banks are out to sell assets they took over during the crisis</description><pubDate>Thu, 9 Feb 2012 20:02:10 +0000</pubDate><ft:uid>e1366b70-533f-11e1-aafd-00144feabdc0</ft:uid></item><item><title>ADHD drugs prove beneficial to Shire </title><link>http://www.ft.com/cms/s/0/65cb4e4a-5341-11e1-950d-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/65cb4e4a-5341-11e1-950d-00144feabdc0.html?ftcamp=rss</guid><description>UK drugs group reports 23% increase in revenues to $4.3bn, helped by its treatments for attention deficit and hyperactivity disorder</description><pubDate>Thu, 9 Feb 2012 19:51:10 +0000</pubDate><ft:uid>65cb4e4a-5341-11e1-950d-00144feabdc0</ft:uid></item><item><title>Sanofi to receive $270m payment from Apotex</title><link>http://www.ft.com/cms/s/0/de349f96-5254-11e1-a155-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/0/de349f96-5254-11e1-a155-00144feabdc0.html?ftcamp=rss</guid><description>Settlement brings to an end a decade-long legal dispute over rights to the blockbuster blood thinner Plavix, which generated €7bn in sales in 2011</description><pubDate>Wed, 8 Feb 2012 20:15:11 +0000</pubDate><ft:uid>de349f96-5254-11e1-a155-00144feabdc0</ft:uid></item></channel></rss>






    



